Cargando…
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome
Expression of type 5 phosphodiesterase (PDE5), a cGMP-specific hydrolytic enzyme, is frequently altered in human cancer, but its specific role in tumorigenesis remains controversial. Herein, by analyzing a cohort of 69 patients affected by glioblastoma multiforme (GBM) who underwent chemo- and radio...
Autores principales: | Cesarini, Valeriana, Martini, Maurizio, Vitiani, Lucia Ricci, Gravina, Giovanni Luca, Agostino, Silvia Di, Graziani, Grazia, D'Alessandris, Quintino Giorgio, Pallini, Roberto, Larocca, Luigi M, Rossi, Pellegrino, Jannini, Emmanuele A, Dolci, Susanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355091/ https://www.ncbi.nlm.nih.gov/pubmed/28099939 http://dx.doi.org/10.18632/oncotarget.14656 |
Ejemplares similares
-
Biomarkers for glioblastoma multiforme: status quo
por: Montano, Nicola, et al.
Publicado: (2016) -
Type 5 phosphodiesterase (PDE5) and the vascular tree: From embryogenesis to aging and disease
por: Cesarini, Valeriana, et al.
Publicado: (2020) -
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
por: Martini, Maurizio, et al.
Publicado: (2018) -
Brain Invasion along Perivascular Spaces by Glioma Cells: Relationship with Blood–Brain Barrier
por: Pacioni, Simone, et al.
Publicado: (2019) -
Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
por: Buccarelli, Mariachiara, et al.
Publicado: (2018)